Evogene (EVGN) Q1 2024 Earnings
EVGN·Reported May 23, 2024·Before market open
Evogene reported Q1 2024 revenue of $4.2M, beat analyst consensus of $3.5M by $690.0K. Diluted EPS came in at $-0.80, missed the $-0.09 consensus by $0.71.
Revenue
$4.2Mbeat by $690.0K
Consensus: $3.5MDiluted EPS
$-0.80missed by $0.71
Consensus: $-0.09
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2024 Earnings FAQ
Common questions about Evogene's Q1 2024 earnings report.
Evogene (EVGN) reported Q1 2024 earnings on May 23, 2024 before market open.
Evogene reported revenue of $4.2M and diluted EPS of $-0.80 for Q1 2024.
Revenue beat the consensus estimate of $3.5M by $690.0K. EPS missed the consensus estimate of $-0.09 by $0.71.